Search Results 91-100 of 17338 for hba1c

1. A Study Of Olezarsen (ISIS 678354) Administered To Participants With Severe Hypertriglyceridemia - Mayo Clinic

   Participation eligibility · Hemoglobin A1c (HbA1c) ≥ 9.5% at Screening. · Alanine aminotransferase or aspartate aminotransferase > 3.0 × upper limit of normal.

2. Control-IQ Technology in Individuals with Type 2 Diabetes - Mayo Clinic

   HbA1c ≥ 7.5% and ≤ 12% at screening. Has current glucagon product to treat severe hypoglycemia (injectable or nasal) at home (will provide prescription if ...

4. Screening strategies for prevalent esophageal adenocarcinoma may be different from those recommended for Barrett's esophagus - Mayo Clinic

   HbA1c and alanine aminotransferase levels also were significantly higher in patients with BE compared with patients with EAC . Coronary artery disease was ...

5. A Study To Establish A Biobank Of Blood Samples To Study The Relationship Between Diabetes Mellitus And Other Pancreatic Conditions - Mayo Clinic

   Hemoglobin A1c (HbA1c) ≥ 6.5%; Random Blood Glucose (RBG) ≥200 mg/dl; 2h Post Glucose (PG) ≥200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test).

6. Safety And Feasibility Of Novel Therapy For Duodenal Mucosal Regeneration For Type II Diabetes (REGENT-1-US) - Mayo Clinic

   HbA1C of 7.5-10.0%, inclusive. BMI 24-40 kg/m^2, inclusive. On two to three non-insulin glucose lowering mediations, with one at maximum tolerated dose and ...

7. Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus - Mayo Clinic

   Subjects with HbA1c > 8%; Females who are pregnant or breastfeeding; Concomitant use of appetite suppressants, orlistat, phentermine-topiramate ER or ...

8. rs7903146 genotype on islet GLP-1 production in humans - Mayo Clinic

   HbA1c ³ 6.5%; Use of any glucose-lowering agents including metformin or sulfonylureas. For female subjects: positive pregnancy test at the time of enrollment ...

9. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   HbA1c >=48 millimoles per mole (mmol/mol) (>=6.5%) at screening. Bone fracture within 6 months prior to screening, or presence of a known unresolved or ...

10. Study To Evaluate The Safety, Tolerability, PDs, And Efficacy Of CNP-104 In Subjects With Primary Biliary Cholangitis - Mayo Clinic

    Subjects with uncontrolled diabetes, as defined by HbA1c > 7%. Subjects who have used biologic agents including anti-cell and anti-cytokine therapies within ...